Literature DB >> 16774630

Levetiracetam in Meige's syndrome.

N Yardimci1, M Karatas, M Kilinc, S Benli.   

Abstract

The spontaneous occurrence of blepharospasm and dystonic movements in face muscles, particularly those of the perioral and mandibular regions, has been named as Meige's disease which was first described by Henry Meige in 1910. We report the case of a woman with Meige's syndrome whose symptoms improved with the use of levetiracetam.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774630     DOI: 10.1111/j.1600-0404.2006.00624.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

Review 1.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

Review 2.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

3.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

4.  Blepharospasm: A genetic screening study in 132 patients.

Authors:  Monia Hammer; Alexandra Abravanel; Elizabeth Peckham; Ava Mahloogi; Elisa Majounie; Mark Hallett; Andrew Singleton
Journal:  Parkinsonism Relat Disord       Date:  2019-04-02       Impact factor: 4.891

Review 5.  Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update.

Authors:  Hongying Ma; Jian Qu; Liangjun Ye; Yi Shu; Qiang Qu
Journal:  Front Neurol       Date:  2021-03-29       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.